| __timestamp | Gilead Sciences, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2983000000 | 17992000000 |
| Thursday, January 1, 2015 | 3426000000 | 22400000000 |
| Friday, January 1, 2016 | 3398000000 | 23910000000 |
| Sunday, January 1, 2017 | 3878000000 | 23813000000 |
| Monday, January 1, 2018 | 4056000000 | 24694000000 |
| Tuesday, January 1, 2019 | 4381000000 | 23557000000 |
| Wednesday, January 1, 2020 | 5151000000 | 25436000000 |
| Friday, January 1, 2021 | 5246000000 | 24586000000 |
| Saturday, January 1, 2022 | 5673000000 | 27295000000 |
| Sunday, January 1, 2023 | 6090000000 | 34205000000 |
| Monday, January 1, 2024 | 6091000000 | 28113000000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical and retail sectors, managing Selling, General, and Administrative (SG&A) expenses is crucial for profitability. Gilead Sciences, Inc. and Walgreens Boots Alliance, Inc. have shown contrasting approaches over the past decade. From 2014 to 2023, Gilead Sciences saw a steady increase in SG&A expenses, rising by approximately 104% from $3 billion to $6 billion. In contrast, Walgreens Boots Alliance maintained a more consistent trajectory, with expenses fluctuating around $23 billion to $25 billion, peaking at $28 billion in 2024. This suggests that while Gilead is expanding its operational scope, Walgreens is focusing on efficiency. The data highlights the importance of strategic cost management in sustaining competitive advantage and profitability in their respective industries.
Comparing SG&A Expenses: Novartis AG vs Gilead Sciences, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated
Gilead Sciences, Inc. vs Alnylam Pharmaceuticals, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Gilead Sciences, Inc. vs Regeneron Pharmaceuticals, Inc.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Breaking Down SG&A Expenses: Gilead Sciences, Inc. vs BioCryst Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Merus N.V.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?